Preglomerular Sudanophilia in L-NAME Hypertensive Rats: Involvement of Endothelin

Hypertension

Volumn 27, Issue 3 I, 1996, Pages 382-391

  Bouriquet, Nathalie ^a   Dupont, Madeleine ^a   Herizi, Abderraouf ^a   Mimran, Albert ^a   Casellas, Daniel ^a  

^a Hopital Saint Charles   (France)

Author keywords

Atherosclerosis; Bosentan; Glomerulopathy; L NAME; Losartan; Nitric oxide; Renal arteries

Indexed keywords

BOSENTAN; ENDOTHELIN; INTERCELLULAR ADHESION MOLECULE 1; LOSARTAN; LOSARTAN POTASSIUM; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; GLOMERULOPATHY; HISTOLOGY; HYPERTENSION; IMMUNOHISTOCHEMISTRY; KIDNEY BLOOD FLOW; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ANIMALS; ARGININE; CELL DIVISION; ENDOTHELINS; HYPERTENSION; KIDNEY GLOMERULUS; LIPID METABOLISM; MALE; NG-NITROARGININE METHYL ESTER; RATS; STAINING AND LABELING;

EID: 0029881846     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.27.3.382     Document Type: Article

References (37)

1. Raij L. Mechanisms of vascular injury: the emerging role of the endothelium. J Am Soc Nephrol. 1991;2(suppl 1):S2-S8.
2. Holtz J, Goetz RM. Vascular renin-angiotensin system, endothelial function and atherosclerosis? Basic Res Cardiol. 1994;89(suppl 1):71-86.
3. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
4. Alexander RW. Hypertension and the pathogenesis of atherosclerosis: oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension. 1995;25:155-161.
5. Ketteler M, Border WA, Noble NA. Cytokines and L-arginine in renal injury and repair. Am J Physiol. 1994;267:F197-F207.
6. Baylis C, Mitruka B. Deng A. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest. 1992;90:278-281.
7. Ribeiro MO. Antunes E, de Nucci G. Lovisolo SM, Zatz R. Chronic inhibition of nitric oxide synthesis: a new model of arterial hypertension. Hypertension. 1992;20:298-303.
8. Salazar FJ, Pinilla JM, Lopez F, Romero JC, Quesada T. Renal effects of prolonged synthesis inhibition of endothelium-derived. nitric oxide. Hypertension. 1992;20:113-117.
9. Pollock DR, Polakowski JS, Divish BJ, Opgenorth TJ. Angiotensin blockade reverses hypertension during long-term nitric oxide synthase inhibition. Hypertension. 1993;21:660-666.
10. Jover B, Herizi A. Ventre F. Dupont M. Mimran A. Sodium and angiotensin in hypertension induced by long-term nitric oxide blockade. Hypertension. 1993;21:944-948.
11. Fernandez-Rivas A, Garcia-Estan J, Vargas F. Effects of chronic increased salt intake on nitric oxide synthesis inhibition-induced hypertension. J Hypertens. 1995;13:123-128.
12. Fujihara CK, Michellazzo SM, de Nucci G. Zatz R. Sodium excess aggravates hypertension and renal parenchymal injury in rats with chronic NO inhibition. Am J Physiol. 1994;266:F697-F705.
13. Helmchen U, Kneissler U, Bohle RM, Reher A, Groene HJ. Adaptation and decompensation of intrarenal small arteries in experimental hypertension. J Cardiovasc Pharmacol. 1984:6(suppl 4):S696-S705.
14. Johnson RJ, Alpers CE, Yoshimura A, Lombardi D, Pritzl P, Floege J, Schwartz SM. Renal injury from angiotensin II-mediated hypertension. Hypertension. 1992;19:464-474.
15. Casellas D, Dupont M, Kaskel FJ, Inagami T, Moore LC. Direct visualization of renin-cell distribution in preglomerular vascular trees dissected from rat kidney. Am J Physiol. 1993;265:F151-F156.
16. Lievens MM, Ketelslegers JM, Loots F, Eyndels C. Immunonephelometric method evaluated for determining low concentrations of albumin in urine. Clin Chem. 1988;34:992. Abstract.
17. Dijkstra CD, Döpp EA, Joling P, Kraal G. The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology. 1985;54:589-599.
18. Kurki P, Vanderlaan M, Dolbeare F, Gray J, Tan EM. Expression of proliferating cell nuclear antigen (PCNA)/cyclin during the cell cycle. Exp Cell Res. 1986;166:209-219.
19. Carey AV, Carey RM, Gomez RA. Expression of α-smooth muscle actin in the developing kidney vasculature. Hypertension. 1992; 19(suppl II):II-168-II-175.
20. Diamond JR, Ding G, Frye J, Pesek-Diamond I. Glomerular macrophages and the mesangial proliferative response in the experimental nephrotic syndrome. Am J Pathol. 1992;141:887-894.
21. Fyfe AI, Qiao J-H, Lusis AJ. Immune-deficient mice develop typical atherosclerotic fatty streaks when fed an atherogenic diet. J Clin Invest. 1994;94:2516-2520.
22. Bouriquet N, Casellas D. Chronic L-NAME hypertension in rats and autoregulation of juxtamedullary preglomerular vessels. Am J Physiol. 1995;269:F190-F197.
23. Ujiie K, Yuen J, Hogarth L, Danziger R, Star RA. Localization and regulation of endothelial NO synthase mRNA expression in rat kidney. Am J Physiol. 1994;267:F296-F302.
24. Wilens SL, Elster SK. The role of lipid deposition in renal arteriolar sclerosis. Am J Med Sci. 1951;219:183-196.
25. Wheeler DC, Chana RS. Interactions between lipoproteins, glomerular cells and matrix. Miner Electrolyte Metab. 1993;19: 149-164.
26. Majno G, Zand T. Nunnari J, Kowala MC, Joris I. Intimal responses to shear stress, hypercholesterolemia, and hypertension: studies in the rat aorta. In: Simionescu N, Simionescu M, eds. Endothelial Cell Biology: New York, NY: Plenum Publishing Corp; 1988:349-367.
27. Pesek-Diamond I, Ding G, Frye J, Diamond JR. Macrophages mediate adverse effects of cholesterol feeding in experimental nephrosis. Am J Physiol. 1992;263:F776-F783.
28. Kamanna VS, Vora S, Roh D, Kirschenbaum MA. Comparative studies on acid cholesterol esterase in renal blood vessels and aorta of control and hypercholesterolemic rabbits. Atherosclerosis. 1992;94:27-33.
29. Goldby FS, Beilin LJ. Relationship between arterial pressure and the permeability of arterioles to carbon particles in acute hypertension in the rat. Cardiovasc Res. 1972;6:384-390.
30. Goldby FS, Beilin LJ. How an acute rise in arterial pressure damages arterioles: electron microscopic changes during angiotensin infusion. Cardiovasc Res. 1972;6:569-584.
31. Wilson SK, Heptinstall RH. Effects of acute, angiotensin-induced hypertension on intrarenal arteries in the rat. Kidney Int. 1984;25: 492-501.
32. Dubey RK, Roy A, Overbeck HW. Culture of renal arteriolar smooth muscle cells: mitogenic responses to angiotensin II. Circ Res. 1992;71:1143-1152.
33. Nielsen LB, Slender S, Kjeldsen K, Nordestgaard BG. Effect of angiotensin II and enalapril on transfer of low-density lipoprotein into aortic intima in rabbits. Circ Res. 1994;75:63-69.
34. Keidar S, Brook JG, Aviram M. Angiotensin II enhances lipid peroxidation of low-density lipoprotein. News Physiol Sci. 1993;8:245-248.
35. Li JS, Larivière R, Schiffrin EL. Effect of a nonselective endothelin antagonist on vascular remodeling in deoxycurticosterone acetate-salt hypertensive rats: evidence for a role of endothelin in vascular hypertrophy. Hypertension. 1944;24:183-188.
36. Larivière R, Thibault G, Schiffrin EL. Increased endothelin-1 content in blood vessels of deoxycorticosterone acetate-salt hypertensive but not in spontaneously hypertensive rats. Hypertension. 1993;21:294-300.
37. Kowala MC, Rose PM, Stein PD, Goller N, Recce R, Beyer S, Valentine M, Barton D, Durham SK. Selective blockade of the endothelin subtype A receptor decreases early atherosclerosis in hamsters fed cholesterol. FASEB J. 1995;9:A854. Abstract.